315 related articles for article (PubMed ID: 16443733)
1. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Massi D; Puig S; Franchi A; Malvehy J; Vidal-Sicart S; González-Cao M; Baroni G; Ketabchi S; Palou J; Santucci M
J Clin Pathol; 2006 Feb; 59(2):166-73. PubMed ID: 16443733
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
3. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
4. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivity.
Cianfarani F; Mastroeni S; Odorisio T; Passarelli F; Cattani C; Mannooranparampil TJ; Fortes C; Failla CM
J Cutan Pathol; 2012 Sep; 39(9):826-34. PubMed ID: 22804631
[TBL] [Abstract][Full Text] [Related]
6. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
7. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis and its correlation with the VEGF expression and the sentinel lymph node in cutaneous melanomas.
Buzrla P; Dvorackova J; Motyka O
Biomed Res Int; 2014; 2014():372979. PubMed ID: 25089267
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis.
Shayan R; Karnezis T; Murali R; Wilmott JS; Ashton MW; Taylor GI; Thompson JF; Hersey P; Achen MG; Scolyer RA; Stacker SA
Histopathology; 2012 Oct; 61(4):702-10. PubMed ID: 22734806
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic vessel density and VEGF-C expression as independent predictors of melanoma metastases.
Špirić Z; Eri Ž; Erić M
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1653-1659. PubMed ID: 28756123
[TBL] [Abstract][Full Text] [Related]
12. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma.
Pastushenko I; Vermeulen PB; Vicente-Arregui S; Van den Eynden GG; Alvarez-Alegret R; Querol I; Rutten A; Carapeto FJ; Dirix LY; Van Laere S
J Cutan Pathol; 2015 Oct; 42(10):699-711. PubMed ID: 26264662
[TBL] [Abstract][Full Text] [Related]
13. Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
Gallego E; Vicioso L; Alvarez M; Hierro I; Pérez-Villa L; Blanes A; Matilla A
Virchows Arch; 2011 May; 458(5):621-30. PubMed ID: 21279519
[TBL] [Abstract][Full Text] [Related]
14. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.
Dadras SS; Lange-Asschenfeldt B; Velasco P; Nguyen L; Vora A; Muzikansky A; Jahnke K; Hauschild A; Hirakawa S; Mihm MC; Detmar M
Mod Pathol; 2005 Sep; 18(9):1232-42. PubMed ID: 15803182
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
16. Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma.
Pastushenko I; Van den Eynden GG; Vicente-Arregui S; Prieto-Torres L; Alvarez-Alegret R; Querol I; Dirix LY; Carapeto FJ; Vermeulen PB; Van Laere SJ
Am J Dermatopathol; 2016 May; 38(5):338-46. PubMed ID: 26909582
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
18. The role of VEGF-C staining in predicting regional metastasis in melanoma.
Boone B; Blokx W; De Bacquer D; Lambert J; Ruiter D; Brochez L
Virchows Arch; 2008 Sep; 453(3):257-65. PubMed ID: 18679715
[TBL] [Abstract][Full Text] [Related]
19. Tumor lymphangiogenesis and melanoma metastasis.
Rinderknecht M; Detmar M
J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
